Real-world evidence of combined treatment of biologics and exclusive enteral nutrition in patients with ileum-dominant Crohn's disease: A multicenter study-Reference-Cited by-同舟云学术

Real-world evidence of combined treatment of biologics and exclusive enteral nutrition in patients with ileum-dominant Crohn's disease: A multicenter study

Published:2024-06 Issue:6 Volume:43 Page:1291-1298
ISSN:0261-5614
Container-title:Clinical Nutrition
language:en
Short-container-title:Clinical Nutrition

Author:

Wang Wei,Yin Anning,Wang Jing,Li Jiao,Cheng Jingyun,Kang Jian,Xu Yaqing,Lu Yueyue,Yang Yuanping,Su Juan,Zhou Qian,Liu Ya,Tang Zhishun^ORCID,Ren Haixia,Li Weiwei,Dong Weiguo,Yu Baoping,An Ping

Publisher

Elsevier BV

Reference42 articles.

1. Improving food-related quality of life in inflammatory bowel disease through a novel web resource: a feasibility randomised controlled trial;Cox;Nutrients,2022

2. Ustekinumab as induction and maintenance therapy for Crohn’s disease;Feagan;N Engl J Med,2016

3. Efficacy of ustekinumab for inducing endoscopic healing in patients with Crohn’s disease;Rutgeerts;Gastroenterology,2018

4. Ustekinumab induction and maintenance therapy in refractory Crohn’s disease;Sandborn;N Engl J Med,2012

5. Treatment patterns and sequencing in patients with inflammatory bowel disease;Brady;Clin Therapeut,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Letter to the editor: Real-world evidence of combined treatment of biologics and exclusive enteral nutrition in patients with ileum-dominant Crohn's disease: A multicenter study;Clinical Nutrition ESPEN;2024-10

2. Evaluating Efficacy of Vedolizumab, Ustekinumab, and Golimumab in the Management of Inflammatory Bowel Disease and the Combined Role of Nutritional Therapy with Biologics: A Review;Biologics;2024-08-30